About: Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Jeitany Maya, Leroy Cédric, Tosti Priscillia, Lafitte Marie, Le Guet Jordy, Simon Valérie, Bonenfant Debora, Robert Bruno, Grillet Fanny, Mollevi Caroline, El Messaoudi Safia, Otandault Amaëlle, Canterel-Thouennon Lucile, Busson Muriel, Thierry Alain R, Martineau Pierre, Pannequin Julie, Roche Serge, Sirvent Audrey. Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. EMBO Molecular Medicine, Wiley Open Access, 2018, 10 (4), pp.e7918. ⟨10.15252/emmm.201707918⟩
  • Jeitany Maya, Leroy Cédric, Tosti Priscillia, Lafitte Marie, Le Guet Jordy, Simon Valérie, Bonenfant Debora, Robert Bruno, Grillet Fanny, Mollevi Caroline, El Messaoudi Safia, Otandault Amaëlle, Canterel-Thouennon Lucile, Busson Muriel, Thierry Alain R, Martineau Pierre, Pannequin Julie, Roche Serge, Sirvent Audrey. Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. EMBO Molecular Medicine, 2018, 10 (4), pp.e7918. ⟨10.15252/emmm.201707918⟩
Title
  • Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
dc:date
  • 2018
Digital Object Identifier (DOI)
  • 10.15252/emmm.201707918
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software